Skip to content

A Randomized Trial of Recommendations for Exercise to Prevent Weight Regain

A Randomized Trial of Recommendations for Exercise to Prevent Weight Regain

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01664715
Acronym
POWeR
Enrollment
287
Registered
2012-08-14
Start date
2012-08-31
Completion date
2018-12-31
Last updated
2019-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity, Overweight, Weight Loss

Keywords

Overweight, Obesity, Exercise, Weight Loss

Brief summary

The investigators will conduct a randomized trial to evaluate the effectiveness of 3 levels of recommended exercise in initially overweight and obese sedentary men and women on the prevention of weight regain. Participants will complete a 3 mo. weight loss intervention of decreased energy intake (EI) and increased energy expenditure (100 minutes of physical activity per week). Participants achieving clinically significant weight loss (\> 5% of initial weight), will be randomly assigned to 12 mos. of exercise at levels of energy expenditure of exercise (EEEx) recommended by Health and Human Services (HHS), American College of Sports Medicine(ACSM), Institute of Medicine (IOM): 150, 225, or 300 minutes per week. Major outcome assessments will occur prior to weight loss (-3 mos.), at completion of weight loss (0 mos.), at the midpoint (6 mos.), and completion of weight maintenance (12 mos.).

Detailed description

The investigators propose a randomized trial in 287 overweight and obese, sedentary adults (at least 50% women). Participants achieving clinically significant weight loss (≥5%) following a 3 mo. reduced energy diet and a program of PA (100 min/wk) will be randomly assigned to either maintain exercise at 150 min/wk. or increase exercise to 225 min/wk or 300 min/wk. while consuming a weight gain prevention diet over a 12 mo. period. Exercise will be verified (combination of on-site and HR monitor) and EEEx will be measured at 5 mo. intervals beginning at mo. 5. In-person behaviorally based clinic meetings will be conducted weekly during the 3 mo. weight loss period (-3 to 0 mos.) and during the first 3 mos. of the weight regain prevention period. During the final 9 mos. of weight regain prevention, clinics will be held bi-monthly using group conference calls. We have not proposed to randomize participants to a true control group (i.e. no exercise or diet) following the 3 mo. weight loss program as published data indicates significant weight regain in individuals receiving no follow-up treatment after weight loss.

Interventions

BEHAVIORAL150 Min/Week

Performs 150 min/wk of planned moderate intensity aerobic exercise.

BEHAVIORAL225 Min/Week

Performs 225 min/wk of planned moderate intensity aerobic exercise.

BEHAVIORAL300 Min/Week

Performs 300 min/wk of planned moderate intensity aerobic exercise.

Sponsors

National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH
University of Kansas
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

* Age 21 to 55 years. * BMI of 25 to 45.0. * Clearance for participation from their Primary Care Physician (PCP)

Exclusion criteria

* Participation in a research project involving weight loss or exercise in the previous 6 mos., as these proximal experiences may impact the results of this study. * Participation in a regular exercise program (i.e., \> 500 kcal/wk. of planned activity as estimated by questionnaire) * Not weight stable (+ or - 4.5 kg) for 3 mos. prior to intake. * Unwilling to be randomized to 1 of 3 exercise groups subsequent to weight loss. * Pregnant during the previous 6 mos., lactating, or planned pregnancy in the following 15 mos. * Serious medical risk such as type 1 diabetes, cancer, recent cardiac event (i.e., heart attack, angioplasty, etc.). This is determined by the individual's physician via the clearance to participate in the investigation and the health history (Appendix) interpreted by the staff physician. * Eating disorders as determined by the Eating Attitudes Test using a score of 20 or greater * Current treatment for psychological problems, or taking psychotropic medications * Medications known to significantly affect weight (gain or loss). * Adherence to specialized diet regimens, i.e., multiple food allergies, vegetarian, macrobiotic, etc. * Do not have access to grocery shopping and meal preparation (i.e. those in military, college with cafeteria plan, etc.).

Design outcomes

Primary

MeasureTime frameDescription
Prevention of Weight Regain12 MonthsTo compare the effectiveness of 3 exercise recommendations on the prevention of weight regain over 12 mos. subsequent to clinically significant weight loss (\> 5%). We expect participants will regain weight in a dose-response manner, i.e. greatest, intermediate and least weight regain for the 150, 225, and 300 minute. groups, respectively.
Gender Differences in Weight Regain12 MonthsTo evaluate gender differences in weight regain over 12 months in response to 3 exercise recommendations. Based on available preliminary data we expect men will regain less weight than women.

Secondary

MeasureTime frameDescription
Compensatory Changes to three exercise levels12 MonthsEvaluating the impact of potential compensatory changes in daily physical activity and energy intake on weight regain in response to 3 exercise recommendations. Any observed compensatory responses would inform the development of subsequent targeted interventions.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026